Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis-Reference-Cited by-同舟云学术

Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis

Published:2021-07 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Younossi Zobair M.^ORCID,Stepanova Maria,Nader Fatema,Loomba Rohit,Anstee Quentin M.,Ratziu Vlad,Harrison Stephen,Sanyal Arun J.,Schattenberg Jörn M.,Barritt A. Sidney,Noureddin Mazen,Bonacci Martin,Cawkwell Gail,Wong Bruce,Rinella Mary

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. Diagnosis and assessment of NAFLD: definitions and histopathological classification;Burt;Semin Liver Dis,2015

2. Design and validation of a histological scoring system for nonalcoholic fatty liver disease;Kleiner;Hepatology,2005

3. The patient perspectives on future therapeutic options in NASH and patient needs;Cook;Front Med,2019

4. Patients with non-alcoholic steatohepatitis (NASH) have worse Health Related Quality of Life (HRQOL) than matched controls: results from the 2016 EU5 National Health and Wellness Survey (NHWS). Poster PGI48;Balp;Value Health,2018

5. The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: a real-world patient reported outcomes study;Balp;JHEP Rep,2019

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current strategies for nonalcoholic fatty liver disease treatment (Review);International Journal of Molecular Medicine;2024-08-08

2. The role of botanical triterpenoids and steroids in bile acid metabolism, transport, and signaling: Pharmacological and toxicological implications;Acta Pharmaceutica Sinica B;2024-08

3. Protecting liver health with microbial-derived succinylated bile acids;Life Metabolism;2024-06-13

4. Exploring the potential of drug repurposing for liver diseases: A comprehensive study;Life Sciences;2024-06

5. A microbial-derived succinylated bile acid to safeguard liver health;Cell;2024-05